Orbital Artery Doppler Ultrasound in Brain Death
Launched by KORGÜN ÖKMEN · Jan 17, 2024
Trial Information
Current as of June 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • suspected brain death
- Exclusion Criteria:
- • eye surgery,
- • uncontrolled diabetes mellitus,
- • facial trauma,
- • hypothermia,
- • hypotension (systolic pressure \< 100 mm Hg)
- • endocrine-metabolic coma
About Korgün ökmen
Korgün Ökmen is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a strong focus on improving patient outcomes, Korgün Ökmen collaborates with healthcare professionals and research institutions to design and implement rigorous clinical trials across various therapeutic areas. Leveraging a deep understanding of regulatory requirements and clinical best practices, the organization aims to ensure the integrity of data and the safety of participants while contributing to the development of effective treatments and therapies. Through a steadfast commitment to scientific excellence and ethical standards, Korgün Ökmen strives to make a meaningful impact in the field of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bursa, , Turkey
Patients applied
Trial Officials
Korgün Ökmen
Principal Investigator
UNIVERSITY OF HEALTH SCIENCES BURSA YUKSEK IHTISAS TRAINING AND RESEARCH HOSPITAL
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported